Aytu BioPharma Statistics
NASDAQ: AYTUHealthcareDrug Manufacturers - Specialty & GenericUSD
2.050.00 (0.00%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Aytu BioPharma by the numbers
Aytu BioPharma has a market capitalization of $22.3 million based on 10.87M shares outstanding. With trailing EPS of $-1.16, Aytu BioPharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.4% below its 50-day average and 13.6% below its 200-day average.
Average daily trading volume is 34.22K shares, or about $70,157 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AYTU valuation vs. peer median
| Metric | AYTU | Peer median | Difference |
|---|---|---|---|
| Market cap | $22.28M | $22.13M | +1% |
| Forward P/E | 13.2 | 5.7 | +130% |
| Avg. volume | 34.22K | 300.47K | -89% |
Peer median across 8 companies: TXMD, OPTH, UPC, SHPH, BFRI, RMTI, CABR, APUS.
Valuation
- Market cap
- $22.28M
- Forward P/E
- 13.23
- EPS (TTM)
- $-1.16
- Shares outstanding
- 10.87M
Price and trading
- Previous close
- 2.05
- Open
- 2.05
- Day range
- 2.05 – 2.09
- 52-week range
- 1.80 – 3.07
- 52-week change
- -13.50%
- Beta
- —
- Volume
- 5.62K
- Average volume
- 34.22K
Dividends and events
- Annual dividend
- None
- Next earnings date
- May 14, 2025
Additional statistics
- Market Cap
- 22.28M
- Forward Pe
- 13.23
- Eps
- -1.16
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.07
- Week52 Low
- 1.80
- Avg Volume
- 34,223.00
- Shares Outstanding
- 10.87M
- Ma50
- 2.21
- Ma200
- 2.37
- Earnings Date
- May 14, 2025
- Pct From52w High
- -33.22%
- Pct From52w Low
- 13.89%